Current and future options for the treatment of chemotherapy-induced anaemia |
| |
Authors: | Ziegler Jennifer A Herrington Jon D |
| |
Institution: | Wake Forest University Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157, USA. |
| |
Abstract: | Chemotherapy-induced anaemia (CIA) is a significant source of morbidity in patients receiving treatment for cancer. There are three products currently available for the treatment of CIA: epoetin alfa, epoetin beta and darbepoetin alfa. Several organisations have published recommendations for the use of these agents. Several randomised, controlled trials have been conducted comparing the most popular dosing regimens of epoetin alfa and darbepoetin alfa, with conflicting results. Information regarding survival and adverse event data related to these agents continues to create debate. This review considers four new agents that are under development for the treatment of CIA. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|